Anand Parikh is Co-Founder & CEO at Faeth Therapeutics, a cancer metabolism biotech company focused on showing world-changing results by combining precise nutrition control with therapeutics to starve cancer tumors. Faeth recently closed its Series A and is actively enrolling patients in clinical trials for endometrial, ovarian, colorectal and pancreatic cancers. Faeth is backed by Khosla Ventures, S2G Ventures, Future Ventures and other investors. Prior to co-founding Faeth, Anand was the CFO of Virta Health, a $2B digital specialty clinic focused on reversing Type 2 Diabetes safely and sustainably.
Previously, Anand was a Corporate Associate at Morrison & Foerster LLP, a Clerk for Chief Judge Gerald Rosen of the Eastern District of Michigan, and a Senate Fellow for the California State Senate. Anand earned a B.A from the University of Michigan and a JD from NYU Law School.